The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 23, 2022
Filed:
Jun. 02, 2017
Applicant:
Ultimovacs As, Oslo, NO;
Inventors:
Gustav Gaudernack, Sandvika, NO;
Audun Tornes, Drammen, NO;
Assignee:
Ultimovacs AS, Oslo, NO;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 39/00 (2006.01); C07K 16/28 (2006.01); A61P 35/04 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/001157 (2018.08); A61K 39/0011 (2013.01); A61K 39/00115 (2018.08); A61K 39/001154 (2018.08); A61K 39/39558 (2013.01); A61P 35/00 (2018.01); A61P 35/04 (2018.01); C07K 16/2818 (2013.01); A61K 2039/505 (2013.01); A61K 2039/53 (2013.01); A61K 2039/70 (2013.01); C07K 2317/21 (2013.01); C07K 2317/76 (2013.01);
Abstract
A polypeptide for use in medicine is provided. The polypeptide is administered simultaneously, separately or sequentially with an immune checkpoint inhibitor. The polypeptide comprises at least one polypeptide comprising a region of at least 12 amino acids of a self-antigen or a sequence having at least 80% identity to the region. The polypeptide is less than 100 amino acids in length.